{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:33:16Z","timestamp":1783654396477,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejmech.2019.05.058","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T15:54:10Z","timestamp":1558454050000},"page":"188-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Peat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-8769","authenticated-orcid":false,"given":"Gianluca","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Menicatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-6146","authenticated-orcid":false,"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.05.058_bib2","first-page":"231","article-title":"Advances in understanding nociception and neuropathic pain","volume":"265","author":"St John Smith","year":"2018","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejmech.2019.05.058_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a Review","volume":"6","author":"Fornasari","year":"2017","journal-title":"Pain Ther"},{"key":"10.1016\/j.ejmech.2019.05.058_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2016.00276","article-title":"Current status of the new antiepileptic drugs in chronic pain","volume":"7","author":"Sidhu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.05.058_bib5","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejmech.2019.05.058_bib6","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2019.05.058_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2019.05.058_bib8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A\u00a0class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib9","first-page":"30091","article-title":"Special issue : neuronal protein mobility KCC2 membrane diffusion tunes neuronal chloride homeostasis","volume":"S0028\u20133908","author":"C\u00f4me","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.05.058_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2005.08.007","article-title":"Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus","volume":"48","author":"Halmi","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2019.05.058_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.2015.1066675","article-title":"Acetazolamide for the treatment of idiopathic intracranial hypertension","volume":"15","author":"Supuran","year":"2015","journal-title":"ExpertRev Neurother"},{"key":"10.1016\/j.ejmech.2019.05.058_bib12","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1021\/acs.chemrev.7b00067","article-title":"Recent advances in the synthesis of hydantoins: the state of the art of a valuable scaffold","volume":"117","author":"Konnert","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.05.058_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/anie.201508990","article-title":"Programming a molecular relay for ultrasensitive biodetection through 129Xe NMR","volume":"55","author":"Wang","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.05.058_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib15","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/acsmedchemlett.7b00280","article-title":"Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.058_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acsmedchemlett.8b00076","article-title":"Design, synthesis, and X-ray of selenides as new class of agents for prevention of diabetic cerebrovascular pathology","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.058_bib18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ejmech.2018.08.096","article-title":"Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity","volume":"157","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.05.058_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and midazolam act synergistically to inhibit neuropathic pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2019.05.058_bib21","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1039\/C8NJ00700D","article-title":"Novel functionalized organotellurides with enhanced thiol peroxidase catalytic activity","volume":"42","author":"Tanini","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib22","first-page":"166","article-title":"Novel sulfur and selenium-containing antioxidants: synthesis and evaluation of their GPx-like activity. Phosphorus, Sulfur Silicon Relat","volume":"192","author":"Tanini","year":"2017","journal-title":"Elem"},{"key":"10.1016\/j.ejmech.2019.05.058_bib23","first-page":"1585","article-title":"Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain","volume":"12","author":"Di Cesare Mannelli","year":"2013","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2019.05.058_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2015.05.037","article-title":"Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: a pain mechanismmediated by Pannexin 1","volume":"97","author":"Di Cesare Mannelli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.05.058_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bioorg.2017.12.010","article-title":"First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors","volume":"76","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.058_bib27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/acsmedchemlett.8b00362","article-title":"Heterocoumarins are selective carbonic anhydrase IX and XII inhibitors with cytotoxic effects against cancer cells lines","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.058_bib28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C8CC08562E","article-title":"Selenols: a new class of carbonic anhydrase inhibitors","volume":"55","author":"Angeli","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.05.058_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.05.058_bib30","doi-asserted-by":"crossref","first-page":"905360","DOI":"10.1155\/2013\/905360","article-title":"Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats","volume":"2013","author":"Di Cesare Mannelli","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2019.05.058_bib31","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/jm901298x","article-title":"A\u00a0novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury","volume":"52","author":"Failli","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib32","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm500255y","article-title":"Cyclic secondary sulfonamides: unusually good inhibitors of cancer related carbonic anhydrase enzymes","volume":"57","author":"Moeker","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.058_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.05.058_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1107\/S090744491003982X","article-title":"An introduction to data reduction: space group determination, scaling and intensity statistics","volume":"67","author":"Evans","year":"2011","journal-title":"Acta Crystallogr. D: Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.05.058_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.05.058_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D: Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.05.058_bib37","first-page":"213","article-title":"PHENIX: a comprehensive Python\u2014ased system for macromolecular structure solution","volume":"D66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2019.05.058_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:31:37Z","timestamp":1663497097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419304684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":37,"alternative-id":["S0223523419304684"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.058","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}